Based on the superior bio technology and R&D capability, we have developed various new original medicines like first pediatric growth hormone and nation's first diabetes medicine, and we are expanding our competitive advantages in overseas by business cooperation with global pharmaceutical company.
LDPE (including EVA)
No.1 share in the domestic marketSpecialized/Differentiated Products
69% of whole saleOne of the three
biggest compound makers
Korea's largest LDPE and LLDPE
production facilities
Whois Chemical is positioned as a leading company of Asian synthetic resin market by reorganizing portfolio into high value products which accord with customer's need
not the existing universal products. As a result, HDPE/FMF PP have been selected as world-class products so that our superior product competitiveness was recognized
throughout the world.
Whois chemical will lead the high value Asian synthetic resin market by boosting production through building additional NCC plants, widening market share of Terpolymer
PP, building additional ADL (Advanced Double Loop) plants for increasing output of high value PE products
Synthetic drugs
Esthetic
Diagnostic drugs